BCWORLD PHARM. Co., Ltd.
200780.KQ
Get informed when a big investor buys or sells
+ FollowMarket Cap$30.87B
Close$
Share Statistics
| Market cap | $30.87 Billion |
|---|---|
| Enterprise Value | $114.18 Billion |
| Dividend Yield | $100.00 (3.31%) |
| Earnings per Share | $-527.02 |
| Beta | 0.02 |
| Outstanding Shares | 10,220,760 |
Return
| Return on Equity | -4.17% |
|---|---|
| Return on Assets | -1.67% |
| Return on Invested Capital | 3.45% |
Valuation & Multiples
| P/E Ratio | -9.93 |
|---|---|
| PEG | -19.1 |
| Price to Sales | 0.38 |
| Price to Book Ratio | 0.43 |
| Enterprise Value to Revenue | 1.42 |
| Enterprise Value to EBIT | 40.3 |
| Enterprise Value to Net Income | -40 |
| Total Debt to Enterprise | 0.76 |
| Debt to Equity | 1.25 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About BCWORLD PHARM. Co., Ltd.
288 employees
CEO: Sung-Han Hong BCWORLD PHARM. Co., Ltd. operates as a pharmaceutical enterprise in South Korea, providing a comprehensive range of medical solutions. Its extensive product portfolio addresses diverse therapeutic areas, including the musculoskeletal sys...